Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 64
Filtrar
1.
Toxins (Basel) ; 16(4)2024 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-38668610

RESUMEN

Ribosome-inactivating proteins (RIPs) are a group of proteins with rRNA N-glycosylase activity that irreversibly inhibit protein synthesis and consequently cause cell death. Recently, an RIP called ledodin has been found in shiitake; it is cytotoxic, strongly inhibits protein synthesis, and shows rRNA N-glycosylase activity. In this work, we isolated and characterized a 50 kDa cytotoxic protein from shiitake that we named edodin. Edodin inhibits protein synthesis in a mammalian cell-free system, but not in insect-, yeast-, and bacteria-derived systems. It exhibits rRNA N-glycosylase and DNA-nicking activities, which relate it to plant RIPs. It was also shown to be toxic to HeLa and COLO 320 cells. Its structure is not related to other RIPs found in plants, bacteria, or fungi, but, instead, it presents the characteristic structure of the fold type I of pyridoxal phosphate-dependent enzymes. Homologous sequences have been found in other fungi of the class Agaricomycetes; thus, edodin could be a new type of toxin present in many fungi, some of them edible, which makes them of great interest in health, both for their involvement in food safety and for their potential biomedical and biotechnological applications.


Asunto(s)
Ribosomas , Hongos Shiitake , Humanos , Ribosomas/efectos de los fármacos , Ribosomas/metabolismo , Hongos Shiitake/química , Células HeLa , Animales , Micotoxinas/toxicidad , Micotoxinas/química , Proteínas Inactivadoras de Ribosomas/química , Proteínas Inactivadoras de Ribosomas/farmacología , Proteínas Fúngicas/química , Proteínas Fúngicas/toxicidad , Proteínas Fúngicas/farmacología , Proteínas Fúngicas/metabolismo , Línea Celular Tumoral
2.
Biomed Pharmacother ; 144: 112339, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34656057

RESUMEN

Colorectal cancer is the second deadly cancer in the world. Trametes versicolor is a traditional Chinese medicinal mushroom with a long history of being used to regulate immunity and prevent cancer. Trametes versicolor mushroom extract demonstrates strongly cell growth inhibitory activity on human colorectal tumor cells. In this study, we characterized a novel 12-kDa protein that named musarin, which was purified from Trametes versicolor mushroom extract and showed significant growth inhibition on multiple human colorectal cancer cell lines in vitro. The protein sequence of musarin was determined through enzyme digestion and MS/MS analysis. Furthermore, Musarin, in particular, strongly inhibits aggressive human colorectal cancer stem cell-like CD24+CD44+ HT29 proliferation in vitro and in a NOD/SCID murine xenograft model. Through whole transcription profile and gene enrichment analysis of musarin-treated CSCs-like cells, major signaling pathways and network modulated by musarin have been enriched, including the bioprocess of the Epithelial-Mesenchymal Transition, the EGFR-Ras signaling pathway and enzyme inhibitor activity. Musarin demonstrated tyrosine kinase inhibitory activity in vitro. Musarin strongly attenuated EGFR expression and down-regulated phosphorylation level, thereby slowing cancer cells proliferation. In addition, oral ingestion of musarin significantly inhibited CD24+CD44+ HT29 generated tumor development in SCID/NOD mice with less side effects in microgram doses. Targeting self-renewal aggressive stem-cell like cancer cell proliferation, with higher water solubility and lower cytotoxicity, musarin has shown strong potence to be developed as a promising novel therapeutic drug candidate against colorectal cancers, especially those that acquire chemo-resistance.


Asunto(s)
Antineoplásicos/farmacología , Proliferación Celular/efectos de los fármacos , Neoplasias Colorrectales/tratamiento farmacológico , Proteínas Fúngicas/farmacología , Células Madre Neoplásicas/efectos de los fármacos , Polyporaceae , Inhibidores de Proteínas Quinasas/farmacología , Animales , Antineoplásicos/aislamiento & purificación , Antineoplásicos/toxicidad , Neoplasias Colorrectales/enzimología , Neoplasias Colorrectales/genética , Neoplasias Colorrectales/patología , Receptores ErbB/antagonistas & inhibidores , Receptores ErbB/genética , Receptores ErbB/metabolismo , Proteínas Fúngicas/aislamiento & purificación , Proteínas Fúngicas/toxicidad , Regulación Neoplásica de la Expresión Génica , Redes Reguladoras de Genes , Células HT29 , Humanos , Masculino , Ratones Endogámicos NOD , Ratones SCID , Células Madre Neoplásicas/enzimología , Células Madre Neoplásicas/patología , Polyporaceae/química , Inhibidores de Proteínas Quinasas/aislamiento & purificación , Inhibidores de Proteínas Quinasas/toxicidad , Transducción de Señal , Transcriptoma , Carga Tumoral/efectos de los fármacos , Ensayos Antitumor por Modelo de Xenoinjerto
3.
Food Chem ; 359: 129931, 2021 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-33940474

RESUMEN

Porcini are edible mushrooms widely used in cooking due to their extraordinary taste. Despite this, cases of food poisoning have been reported in the recent literature also for ingestion of porcini. Here, we report the isolation from Boletus edulis fruiting bodies of two novel ribotoxin-like proteins (RL-Ps), enzymes already studied in other organisms for their toxicity. These RL-Ps, named Edulitin 1 (16-kDa) and Edulitin 2 (14-kDa), show peculiar structural and enzymatic differences, which probably reflect their different bio-activities and a dose/time dependent toxicity (Edulitin 2) on normal and tumoral human cells. Particularly interesting is the resistance to proteolysis of Edulitin 2, for which it was observed that its toxicity was abolished only after heat treatment (90 °C) followed by proteolysis. As mushroom poisoning is a serious food safety issue, data here presented confirm the existence of toxins also in porcini and the importance of a proper cooking before their consumption.


Asunto(s)
Basidiomycota/química , Proteínas Fúngicas/química , Proteínas Fúngicas/metabolismo , Toxinas Biológicas/toxicidad , Proteínas Fúngicas/toxicidad , Humanos , Conformación Proteica
4.
Int Immunol ; 33(3): 161-170, 2021 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-33038250

RESUMEN

Candida albicans is a commensal fungus that predominantly resides on mucosal surfaces and can cause lethal systemic infection when the host defense is compromised. Candidalysin is a cytolytic peptide toxin produced by C. albicans hyphae that is essential for mucosal tissue damage and is believed to contribute to the establishment of systemic infection and mortality. Candidalysin is also required for the epithelial innate response in which proinflammatory cytokines and chemokines are produced and neutrophil recruitment is initiated. It was recently reported that epidermal growth factor receptor (EGFR) was essential for the candidalysin-triggered epithelial response. The present study identified IL-1α as another component of candidalysin-mediated initial epithelial activation. We found that human oral epithelial cells released IL-1α rapidly after candidalysin exposure. Blockade of IL-1α/IL-1 receptor (IL-1R) signaling in candidalysin-exposed cells resulted in decreased phosphorylation of IκBα, decreased induction of IκBζ and decreased production of granulocyte-macrophage colony-stimulating factor and IL-8. Expression of c-Fos, which is induced downstream of EGFR signaling in candidalysin-treated cells, is less affected by IL-1R blockade. Inversely, blockade of EGFR signaling does not affect candidalysin-mediated phosphorylation of IκBα and induction of IκBζ, suggesting that independent signaling pathways contribute to the induction of NF-κB and c-Fos downstream of the candidalysin pore formation site. Consistently, antibody inhibition of both EGFR and IL-1R enhanced the suppressive effect of cytokine production in candidalysin-treated cells. Thus, we identified the immediate release of IL-1α and its synergistic role with EGFR ligands on the initial activation of oral epithelial cells in response to candidalysin.


Asunto(s)
Células Epiteliales/inmunología , Proteínas Fúngicas/toxicidad , Interleucina-1alfa/metabolismo , Mucosa Bucal/metabolismo , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Candida albicans/inmunología , Línea Celular , Receptores ErbB/antagonistas & inhibidores , Receptores ErbB/metabolismo , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Humanos , Proteínas I-kappa B/metabolismo , Inmunidad Innata/inmunología , Interleucina-1alfa/antagonistas & inhibidores , Interleucina-8/metabolismo , Mucosa Bucal/citología , Fosforilación , Receptores de Interleucina-1/antagonistas & inhibidores , Receptores de Interleucina-1/metabolismo , Transducción de Señal/fisiología
5.
J Pept Sci ; 26(11): e3278, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32743839

RESUMEN

Presently, echinocandins have been recommended as the first-line drugs for the treatment of invasive candidiasis. However, low oral bioavailability and solubility limit their application. To improve this situation, this study chose amino acid and fatty acid as raw materials to modify the nucleus of echinocandin B. Six N-acylated analogs were screened from the derivatives that possessed potent antifungal activity and good water solubility. Based on antifungal susceptibility and hemolytic toxicity, compound 5 as the candidate had good antifungal activity and no hemolytic effect. Moreover, compared with anidulafungin, compound 5 showed a comparable fungicidal effect, much higher solubility, and lower toxicity. In conclusion, compound 5 has the potential for further research and development on account of reserved antifungal activity, high solubility, and low toxicity.


Asunto(s)
Candida albicans/efectos de los fármacos , Equinocandinas/farmacología , Equinocandinas/toxicidad , Proteínas Fúngicas/farmacología , Proteínas Fúngicas/toxicidad , Macrófagos/efectos de los fármacos , Acilación , Animales , Antifúngicos , Peso Corporal/efectos de los fármacos , Equinocandinas/química , Proteínas Fúngicas/química , Masculino , Ratones , Ratones Endogámicos ICR , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Células RAW 264.7 , Solubilidad
6.
PLoS One ; 15(4): e0231990, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32320453

RESUMEN

Environmental mold (fungus) exposure poses a significant threat to public health by causing illnesses ranging from invasive fungal diseases in immune compromised individuals to allergic hypertensive diseases such as asthma and asthma exacerbation in otherwise healthy people. However, the molecular pathogenesis has not been completely understood, and treatment options are limited. Due to its thermo-tolerance to the normal human body temperature, Aspergillus. fumigatus (A.fumigatus) is one of the most important human pathogens to cause different lung fungal diseases including fungal asthma. Airway obstruction and hyperresponsiveness caused by mucus overproduction are the hallmarks of many A.fumigatus induced lung diseases. To understand the underlying molecular mechanism, we have utilized a well-established A.fumigatus extracts (AFE) model to elucidate downstream signal pathways that mediate A.fumigatus induced mucin production in airway epithelial cells. AFE was found to stimulate time- and dose-dependent increase of major airway mucin gene expression (MUC5AC and MUC5B) partly via the elevation of their promoter activities. We also demonstrated that EGFR was required but not sufficient for AFE-induced mucin expression, filling the paradoxical gap from a previous study using the same model. Furthermore, we showed that fungal proteases in AFE were responsible for mucin induction by activating a Ras/Raf1/ERK signaling pathway. Ca2+ signaling, but ROS, both of which were stimulated by fungal proteases, was an indispensable determinant for ERK activation and mucin induction. The discovery of this novel pathway likely contributes to our understanding of the pathogenesis of fungal sensitization in allergic diseases such as fungal asthma.


Asunto(s)
Aspergillus fumigatus/enzimología , Proteínas Fúngicas/toxicidad , Interacciones Huésped-Patógeno/fisiología , Mucinas/metabolismo , Péptido Hidrolasas/toxicidad , Aspergillus fumigatus/patogenicidad , Calcio/metabolismo , Línea Celular , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Receptores ErbB/metabolismo , Humanos , Pulmón/citología , Sistema de Señalización de MAP Quinasas , Mucina 5AC/genética , Mucina 5AC/metabolismo , Mucina 5B/genética , Mucina 5B/metabolismo , Mucinas/genética , Proteínas Proto-Oncogénicas c-raf/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Proteínas ras/metabolismo
7.
Toxins (Basel) ; 12(4)2020 04 07.
Artículo en Inglés | MEDLINE | ID: mdl-32272814

RESUMEN

Neofusicoccum parvum is a fungal pathogen associated with a wide range of plant hosts. Despite being widely studied, the molecular mechanism of infection of N. parvum is still far from being understood. Analysis of N. parvum genome lead to the identification of six putative genes encoding necrosis and ethylene-inducing proteins (NLPs). The sequence of NLPs genes (NprvNep 1-6) were analyzed and four of the six NLP genes were successfully cloned, expressed in E. coli and purified by affinity chromatography. Pure recombinant proteins were characterized according to their phytotoxic and cytotoxic effects to tomato leaves and to mammalian Vero cells, respectively. These assays revealed that all NprvNeps tested are cytotoxic to Vero cells and also induce cell death in tomato leaves. NprvNep2 was the most toxic to Vero cells, followed by NprvNep1 and 3. NprvNep4 induced weaker, but, nevertheless, still significant toxic effects to Vero cells. A similar trend of toxicity was observed in tomato leaves: the most toxic was NprvNep 2 and the least toxic NprvNep 4. This study describes for the first time an overview of the NLP gene family of N. parvum and provides additional insights into its pathogenicity mechanism.


Asunto(s)
Proteínas Fúngicas/toxicidad , Hojas de la Planta/efectos de los fármacos , Solanum lycopersicum/efectos de los fármacos , Animales , Ascomicetos/genética , Ascomicetos/metabolismo , Supervivencia Celular/efectos de los fármacos , Chlorocebus aethiops , Clorofila/metabolismo , Clonación Molecular , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Solanum lycopersicum/metabolismo , Necrosis , Hojas de la Planta/metabolismo , Proteínas Recombinantes/toxicidad , Células Vero
8.
Prep Biochem Biotechnol ; 50(4): 357-364, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31846385

RESUMEN

In order to obtain a better fermentation parameter for the production of recombinant Ganoderma lucidum immunomodulatory protein (rFIP-glu), an engineered Pichia pastoris GS115 was investigated on the fermentation time, temperature, methanol concentration and initial pH of media, while immunomodulatory activities of the rFIP-glu was confirmed. L9(33) orthogonal experiment were firstly employed to optimize various fermentation parameters in the shake-flask level. The optimized fermentation parameters were subsequently verified in a 5 L fermenter. Biological activities including cell viability and tumor necrosis factor-alpha (TNF-α) mRNA of the rFIP-glu were evaluated on murine macrophage RAW264.7 cells. The results showed that the yield of rFIP-glu was up to 368.71 µg/ml in the shake-flask, and 613.47 µg/ml in the 5 L fermenter, when the Pichia pastoris was incubated in basic media with the methanol concentration 1.0% and initial pH 6.5, and with constant shaking at 280 rpm for 4 days at 26 °C. In vitro assays of biological activity indicated that rFIP-glu had significant toxicity against RAW264.7 cells, and possessed the ability to induce TNF-α mRNA expression in macrophage RAW264.7 cells. In conclusion, engineered P. pastoris showed a good fermentation property under the optimum fermentation parameters. It could be a candidate industrial strain for further study.


Asunto(s)
Reactores Biológicos , Proteínas Fúngicas/biosíntesis , Pichia/metabolismo , Proteínas Recombinantes/biosíntesis , Animales , Fermentación , Proteínas Fúngicas/toxicidad , Ratones , Células RAW 264.7 , Proteínas Recombinantes/toxicidad , Reishi/química , Factor de Necrosis Tumoral alfa/metabolismo
9.
Biotechnol Lett ; 42(1): 125-133, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31720976

RESUMEN

OBJECTIVE: We aimed to investigate the expression of a novel small cysteine-rich (SCR) effector protein SCR96 from the phytopathogenic oomycete Phytophthora cactorum in mammalian cells, its bioactivity and to exploit its polyclonal antibody. RESULTS: The gene encoding the SCR effector protein SCR96 was codon-optimized, custom-synthesized, cloned into pcDNA3.1(-) and overexpressed in human embryonic kidney (HEK) 293-6E cells. The recombinant protein SCR96 was prone to aggregation and purified with its monomer to homogeneity with a predicted molecular weight of 8.9 kDa. SCR96 exhibited strong phytotoxic activity on tomato seedlings at 24 h post treatment with 4.2 µg of the purified protein. An anti-SCR96 polyclonal antibody was prepared by immunization of New Zealand white rabbits. The good-titer antibody had a detection sensitivity at 6.25-ng level and could specifically detect the SCR96 protein expressed either in yeast, or in tomato leaves. CONCLUSIONS: Transient production of the SCR effector protein SCR96 in mammalian cells is reliable, providing sufficient recombinant protein that can be utilized for analysis of its phytotoxic activity and preparation of its polyclonal antibody.


Asunto(s)
Proteínas Fúngicas/biosíntesis , Proteínas Fúngicas/toxicidad , Phytophthora/metabolismo , Solanum lycopersicum/efectos de los fármacos , Factores de Virulencia/biosíntesis , Factores de Virulencia/toxicidad , Animales , Anticuerpos/inmunología , Proteínas Fúngicas/genética , Proteínas Fúngicas/inmunología , Células HEK293 , Humanos , Phytophthora/genética , Conejos , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/toxicidad , Plantones/efectos de los fármacos , Factores de Virulencia/genética , Factores de Virulencia/inmunología
10.
PLoS One ; 13(10): e0204825, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30321182

RESUMEN

Calcium ions (Ca2+) play an important role in the toxicity of the cysteine-rich and cationic antifungal protein PAF from Penicillium chrysogenum: high extracellular Ca2+ levels reduce the toxicity of PAF in the sensitive model fungus Neurospora crassa in a concentration dependent way. However, little is known about the mechanistic details of the Ca2+ ion impact and the Ca2+ binding capabilities of PAF outside the fungal cell, which might be the reason for the activity loss. Using nuclear magnetic resonance (NMR), isothermal titration calorimetry and molecular dynamics (MD) simulations we demonstrated that PAF weakly, but specifically binds Ca2+ ions. MD simulations of PAF predicted one major Ca2+ binding site at the C-terminus involving Asp53 and Asp55, while Asp19 was considered as putative Ca2+ binding site. The exchange of Asp19 to serine had little impact on the Ca2+ binding, however caused the loss of antifungal activity, as was shown in our recent study. Now we replaced the C-terminal aspartates and expressed the serine variant PAFD53S/D55S. The specific Ca2+ binding affinity of PAFD53S/D55S decreased significantly if compared to PAF, whereas the antifungal activity was retained. To understand more details of Ca2+ interactions, we investigated the NMR and MD structure/dynamics of the free and Ca2+-bound PAF and PAFD53S/D55S. Though we found some differences between these protein variants and the Ca2+ complexes, these effects cannot explain the observed Ca2+ influence. In conclusion, PAF binds Ca2+ ions selectively at the C-terminus; however, this Ca2+ binding does not seem to play a direct role in the previously documented modulation of the antifungal activity of PAF.


Asunto(s)
Calcio/metabolismo , Proteínas Fúngicas/química , Proteínas Fúngicas/metabolismo , Penicillium chrysogenum/crecimiento & desarrollo , Sitios de Unión , Calorimetría , Proteínas Fúngicas/genética , Proteínas Fúngicas/toxicidad , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Simulación de Dinámica Molecular , Mutación , Neurospora crassa/efectos de los fármacos , Penicillium chrysogenum/metabolismo , Unión Proteica
11.
Nat Commun ; 9(1): 4260, 2018 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-30323213

RESUMEN

Clearance of invading microbes requires phagocytes of the innate immune system. However, successful pathogens have evolved sophisticated strategies to evade immune killing. The opportunistic human fungal pathogen Candida albicans is efficiently phagocytosed by macrophages, but causes inflammasome activation, host cytolysis, and escapes after hypha formation. Previous studies suggest that macrophage lysis by C. albicans results from early inflammasome-dependent cell death (pyroptosis), late damage due to glucose depletion and membrane piercing by growing hyphae. Here we show that Candidalysin, a cytolytic peptide toxin encoded by the hypha-associated gene ECE1, is both a central trigger for NLRP3 inflammasome-dependent caspase-1 activation via potassium efflux and a key driver of inflammasome-independent cytolysis of macrophages and dendritic cells upon infection with C. albicans. This suggests that Candidalysin-induced cell damage is a third mechanism of C. albicans-mediated mononuclear phagocyte cell death in addition to damage caused by pyroptosis and the growth of glucose-consuming hyphae.


Asunto(s)
Proteínas Fúngicas/toxicidad , Inflamasomas/metabolismo , Leucocitos Mononucleares/citología , Micotoxinas/toxicidad , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Fagocitos/citología , Actinas/metabolismo , Animales , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/metabolismo , Caspasa 1/metabolismo , Muerte Celular/efectos de los fármacos , Células Dendríticas/efectos de los fármacos , Células Dendríticas/metabolismo , Femenino , Humanos , Inflamación/patología , Interleucina-1beta/metabolismo , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/metabolismo , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones Endogámicos C57BL , Necrosis , Fagocitos/efectos de los fármacos , Fagocitos/metabolismo , Fagosomas/efectos de los fármacos , Fagosomas/metabolismo , Potasio/farmacología
12.
Appl Microbiol Biotechnol ; 102(13): 5483-5494, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29705959

RESUMEN

Fungal immunomodulatory proteins (FIPs) have been identified from a series of fungi, especially in Ganoderma species. However, little is known about the FIPs from G. applanatum. In this study, two novel FIP genes, termed as FIP-gap1 and FIP-gap2, were cloned from G. applanatum, characterized and functionally expressed after codon optimization in Pichia pastoris GS115. Results showed that FIP-gap1 and FIP-gap2 comprised 342-bp encoding peptides of 113 amino acids, which shared a high homology with other Ganoderma FIPs. The yield of recombinant FIP-gap1 and FIP-gap2 increased significantly after codon optimization and reached 247.4 and 197.5 mg/L, respectively. Bioactivity assay in vitro revealed that both rFIP-gap1 and rFIP-gap2 could agglutinate mouse, sheep, and human red blood cells. Besides, rFIP-gap1 and rFIP-gap2 obviously stimulated the proliferation of mouse splenocytes and enhanced IL-2 and IFN-γ release. Cytotoxicity detection indicated that IC50 of rFIP-gap1 towards A549 and HeLa cancer cells were 29.89 and 8.34 µg/mL, respectively, whereas IC50 of rFIP-gap2 to the same cancer cells were 60.92 and 41.05 µg/mL, respectively. Taken together, novel FIP gaps were cloned and functionally expressed in P. pastoris, which can serve as feasible and stable resources of rFIP gaps for further studies and potential applications.


Asunto(s)
Codón/genética , Ganoderma/genética , Regulación Fúngica de la Expresión Génica/genética , Pichia/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología , Células A549 , Aglutinación/efectos de los fármacos , Animales , Supervivencia Celular/efectos de los fármacos , Clonación Molecular , Eritrocitos/efectos de los fármacos , Proteínas Fúngicas/genética , Proteínas Fúngicas/farmacología , Proteínas Fúngicas/toxicidad , Células HeLa , Humanos , Factores Inmunológicos/genética , Factores Inmunológicos/farmacología , Factores Inmunológicos/toxicidad , Ratones , Proteínas Recombinantes/toxicidad
13.
Toxins (Basel) ; 9(2)2017 02 21.
Artículo en Inglés | MEDLINE | ID: mdl-28230789

RESUMEN

Fungi establish a complex network of biological interactions with other organisms in nature. In many cases, these involve the production of toxins for survival or colonization purposes. Among these toxins, ribotoxins stand out as promising candidates for their use in biotechnological applications. They constitute a group of highly specific extracellular ribonucleases that target a universally conserved sequence of RNA in the ribosome, the sarcin-ricin loop. The detailed molecular study of this family of toxic proteins over the past decades has highlighted their potential in applied research. Remarkable examples would be the recent studies in the field of cancer research with promising results involving ribotoxin-based immunotoxins. On the other hand, some ribotoxin-producer fungi have already been studied in the control of insect pests. The recent role of ribotoxins as insecticides could allow their employment in formulas and even as baculovirus-based biopesticides. Moreover, considering the important role of their target in the ribosome, they can be used as tools to study how ribosome biogenesis is regulated and, eventually, may contribute to a better understanding of some ribosomopathies.


Asunto(s)
Proteínas Fúngicas , Hongos/enzimología , Micotoxinas , Ribonucleasas , Animales , Biotecnología , Proteínas Fúngicas/metabolismo , Proteínas Fúngicas/toxicidad , Humanos , Micotoxinas/metabolismo , Micotoxinas/toxicidad , Ribonucleasas/metabolismo , Ribonucleasas/toxicidad , Ribosomas
14.
PLoS One ; 12(1): e0169920, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28072824

RESUMEN

The cysteine-rich, cationic, antifungal protein PAF is abundantly secreted into the culture supernatant of the filamentous Ascomycete Penicillium chrysogenum. The five ß-strands of PAF form a compact ß-barrel that is stabilized by three disulphide bonds. The folding of PAF allows the formation of four surface-exposed loops and distinct charged motifs on the protein surface that might regulate the interaction of PAF with the sensitive target fungus. The growth inhibitory activity of this highly stable protein against opportunistic fungal pathogens provides great potential in antifungal drug research. To understand its mode of action, we started to investigate the surface-exposed loops of PAF and replaced one aspartic acid at position 19 in loop 2 that is potentially involved in PAF active or binding site, with a serine (Asp19 to Ser19). We analysed the overall effects, such as unfolding, electrostatic changes, sporadic conformers and antifungal activity when substituting this specific amino acid to the fairly indifferent amino acid serine. Structural analyses revealed that the overall 3D solution structure is virtually identical with that of PAF. However, PAFD19S showed slightly increased dynamics and significant differences in the surface charge distribution. Thermal unfolding identified PAFD19S to be rather a two-state folder in contrast to the three-state folder PAF. Functional comparison of PAFD19S and PAF revealed that the exchange at residue 19 caused a dramatic loss of antifungal activity: the binding and internalization of PAFD19S by target cells was reduced and the protein failed to trigger an intracellular Ca2+ response, all of which are closely linked to the antifungal toxicity of PAF. We conclude that the negatively charged residue Asp19 in loop 2 is essential for full function of the cationic protein PAF.


Asunto(s)
Antifúngicos/química , Proteínas Fúngicas/química , Simulación de Dinámica Molecular , Mutación Missense , Desnaturalización Proteica , Secuencias de Aminoácidos , Antifúngicos/toxicidad , Sitios de Unión , Calcio/metabolismo , Cisteína/química , Proteínas Fúngicas/genética , Proteínas Fúngicas/toxicidad , Penicillium chrysogenum/genética , Penicillium chrysogenum/metabolismo , Unión Proteica
15.
Nature ; 532(7597): 64-8, 2016 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-27027296

RESUMEN

Cytolytic proteins and peptide toxins are classical virulence factors of several bacterial pathogens which disrupt epithelial barrier function, damage cells and activate or modulate host immune responses. Such toxins have not been identified previously in human pathogenic fungi. Here we identify the first, to our knowledge, fungal cytolytic peptide toxin in the opportunistic pathogen Candida albicans. This secreted toxin directly damages epithelial membranes, triggers a danger response signalling pathway and activates epithelial immunity. Membrane permeabilization is enhanced by a positive charge at the carboxy terminus of the peptide, which triggers an inward current concomitant with calcium influx. C. albicans strains lacking this toxin do not activate or damage epithelial cells and are avirulent in animal models of mucosal infection. We propose the name 'Candidalysin' for this cytolytic peptide toxin; a newly identified, critical molecular determinant of epithelial damage and host recognition of the clinically important fungus, C. albicans.


Asunto(s)
Candida albicans/metabolismo , Candida albicans/patogenicidad , Citotoxinas/metabolismo , Proteínas Fúngicas/toxicidad , Micotoxinas/toxicidad , Factores de Virulencia/metabolismo , Calcio/metabolismo , Candida albicans/inmunología , Candidiasis/metabolismo , Candidiasis/microbiología , Candidiasis/patología , Permeabilidad de la Membrana Celular/efectos de los fármacos , Citotoxinas/genética , Citotoxinas/toxicidad , Células Epiteliales/efectos de los fármacos , Células Epiteliales/inmunología , Células Epiteliales/patología , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Interacciones Huésped-Patógeno/inmunología , Humanos , Membrana Mucosa/microbiología , Membrana Mucosa/patología , Micotoxinas/genética , Micotoxinas/metabolismo , Transducción de Señal/efectos de los fármacos , Virulencia/efectos de los fármacos , Factores de Virulencia/genética , Factores de Virulencia/toxicidad
16.
Exp Parasitol ; 161: 6-11, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26706604

RESUMEN

Trichomonas vaginalis is the causative agent of trichomoniasis, the most common nonviral STD worldwide. This infection can lead to severe health conditions, especially when women are affected. Metronidazole and tinidazole are the only choices of treatment. In this sense, natural bioactive compounds against T. vaginalis are an interesting approach in the search for more efficient therapies. Herein, amaurocine, a 12 kDa protein, produced by the mushroom Amauroderma camerarium was purified and tested against T. vaginalis, including two fresh clinical isolates. Amaurocine presented MIC values at 2.6 µM against the ATCC isolate 30236, and 5.2 µM against the fresh clinical isolates, TV-LACH1 and TV-LACM2. Furthermore, besides increasing human neutrophils nitric oxide release, amaurocine presented a low toxicity toward those cells, suggesting it exerts a proinflammatory character.


Asunto(s)
Antiprotozoarios/farmacología , Proteínas Fúngicas/farmacología , Polyporales/metabolismo , Trichomonas vaginalis/efectos de los fármacos , Antiprotozoarios/metabolismo , Antiprotozoarios/toxicidad , Proteínas Fúngicas/biosíntesis , Proteínas Fúngicas/química , Proteínas Fúngicas/toxicidad , Humanos , Pruebas de Sensibilidad Microbiana , Micelio/química , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Óxido Nítrico/metabolismo , Polyporales/química
17.
Biomed Khim ; 61(1): 99-104, 2015.
Artículo en Ruso | MEDLINE | ID: mdl-25762603

RESUMEN

L-Amino acid oxidases (L-ААО, EC 1.4.3.2) comprise a group of flavoproteins, catalyzing oxidative deamination of L-alpha amino acids to the corresponding alpha-keto acids, NH3 and Н2О2. In most cases these enzymes present homodimeric molecules with a molecular mass of 100-150 kDa, which were shown to possess antiviral, antifungal and antitumor activity. L-lysine alpha-oxidase (LO) holds an outstanding place among this group of enzymes and its biological role may differ significantly from the other L-AAO, because it cleaves an essential amino acid - L-lysine without significant action on the other amino acids. Although much research has examined LO effects in the organism, the molecular basis of these effects is yet to be identified. To fill this gap, the present work addressed one of hypothetical mechanisms of LO biological action using the enzyme from Trichoderma cf. aureoviride Rifai ВКМF-4268D and rat pheochromocytoma PC-12 as a model cell line. Using flow cytometry a dose-dependent cytotoxicity of LO was shown. The significant growth of intracellular reactive oxygen species levels, detected by 2,7-dichlorodihydrofluorescein assay, implies generation of peroxide as one of the molecular mechanisms of LO cytotoxic action, although this does not rule out other probable ways of LO action in the organizm.


Asunto(s)
Aminoácido Oxidorreductasas/toxicidad , Proteínas Fúngicas/toxicidad , Trichoderma/enzimología , Animales , Supervivencia Celular , Células PC12 , Ratas
18.
Biochem Biophys Res Commun ; 447(4): 586-9, 2014 May 16.
Artículo en Inglés | MEDLINE | ID: mdl-24747075

RESUMEN

The Marasmius oreades mushroom agglutinin (MOA) is a blood group B-specific lectin carrying an active proteolytic domain. Its enzymatic activity has recently been shown to be critical for toxicity of MOA toward the fungivorous soil nematode Caenorhabditis elegans. Here we present evidence that MOA also induces cytotoxicity in a cellular model system (murine NIH/3T3 cells), by inhibiting protein synthesis, and that cytotoxicity correlates, at least in part, with proteolytic activity. A peptide-array screen identified the apoptosis mediator BAX as a potential proteolytic substrate and further suggests a variety of bacterial and fungal peptides as potential substrates. These findings are in line with the suggestion that MOA and related proteases may play a role for host defense.


Asunto(s)
Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Proteínas Fúngicas/farmacología , Proteína X Asociada a bcl-2/metabolismo , Aglutininas/metabolismo , Aglutininas/farmacología , Aglutininas/toxicidad , Sustitución de Aminoácidos , Animales , Proteínas Fúngicas/metabolismo , Proteínas Fúngicas/toxicidad , Variación Genética , Lectinas/metabolismo , Lectinas/farmacología , Lectinas/toxicidad , Marasmius/química , Marasmius/genética , Ratones , Células 3T3 NIH , Inhibidores de la Síntesis del Ácido Nucleico/farmacología , Inhibidores de la Síntesis del Ácido Nucleico/toxicidad , Inhibidores de la Síntesis de la Proteína/farmacología , Inhibidores de la Síntesis de la Proteína/toxicidad
19.
Mol Plant Microbe Interact ; 26(8): 903-17, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23634836

RESUMEN

Victoria blight, caused by Cochliobolus victoriae, is a disease originally described on oat and recapitulated on Arabidopsis. C. victoriae pathogenesis depends upon production of the toxin victorin. In oat, victorin sensitivity is conferred by the Vb gene, which is genetically inseparable from the Pc2 resistance gene. Concurrently, in Arabidopsis, sensitivity is conferred by the LOCUS ORCHESTRATING VICTORIN EFFECTS1 (LOV1) gene. LOV1 encodes a nucleotide-binding site leucine-rich repeat protein, a type of protein commonly associated with disease resistance, and LOV1 "guards" the defense thioredoxin, TRX-h5. Expression of LOV1 and TRX-h5 in Nicotiana benthamiana is sufficient to confer victorin sensitivity. Virus-induced gene silencing was used to characterize victorin-induced cell death in N. benthamiana. We determined that SGT1 is required for sensitivity and involved in LOV1 protein accumulation. We screened a normalized cDNA library and identified six genes that, when silenced, suppressed LOV1-mediated, victorin-induced cell death and cell death induced by expression of the closely related RPP8 resistance gene: a mitochondrial phosphate transporter, glycolate oxidase, glutamine synthetase, glyceraldehyde 3-phosphate dehydrogenase, and the P- and T-protein of the glycine decarboxylase complex. Silencing the latter four also inhibited cell death and disease resistance mediated by the PTO resistance gene. Together, these results provide evidence that the victorin response mediated by LOV1 is a defense response.


Asunto(s)
Proteínas de Arabidopsis/metabolismo , Proteínas de Unión al ADN/metabolismo , Proteínas Fúngicas/toxicidad , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Silenciador del Gen , Micotoxinas/toxicidad , Nicotiana/metabolismo , Adenoviridae , Proteínas de Arabidopsis/genética , Muerte Celular/efectos de los fármacos , Proteínas de Unión al ADN/genética , Regulación de la Expresión Génica de las Plantas/fisiología , Enfermedades de las Plantas/microbiología , Hojas de la Planta/efectos de los fármacos , Hojas de la Planta/microbiología , Plantas Modificadas Genéticamente , Factores de Tiempo , Nicotiana/genética
20.
Toxicon ; 67: 12-6, 2013 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-23462379

RESUMEN

Ribosome-inactivating proteins (RIPs) either single-chain (type 1) or two-chain (type 2) are frequent in plants, often in multiple forms. They are RNA N-glycosidases, have antiviral, antifungal and insecticidal activity. Their expression in plants is increased under stressful conditions. They are investigated for practical applications in medicine and in agriculture. In medicine, RIPs have been linked to, or fused with, appropriate antibodies or other carriers to form "immunotoxins" or other conjugates specifically toxic to the cells target of the carrier, with the aim of eliminating malignant or other undesired cells. In agriculture, it has been observed that an enhanced expression of RIPs confers to plants an increased resistance to viruses, fungi, insects, and also to drought and salinity.


Asunto(s)
Proteínas Inactivadoras de Ribosomas/toxicidad , Proteínas Inactivadoras de Ribosomas/uso terapéutico , Proteínas Algáceas/uso terapéutico , Proteínas Algáceas/toxicidad , Animales , Antifúngicos , Antivirales , Proteínas Bacterianas/uso terapéutico , Proteínas Bacterianas/toxicidad , Proteínas Fúngicas/uso terapéutico , Proteínas Fúngicas/toxicidad , Humanos , Inmunotoxinas/uso terapéutico , Inmunotoxinas/toxicidad , Insecticidas , Control Biológico de Vectores , Proteínas de Plantas/uso terapéutico , Proteínas de Plantas/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA